#mhc — Thursday, August 13, 2026 (1 items)
| 0 | 💬 0 |
Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression.
(jci.org)
|
Journal of Clinical Investigation 2026-08-13 | #cancer #immunotherapy #amr #mhc #inflammasome |